Squamous Cell Carcinoma of the Head and Neck " at ClinicalTrials.gov Bad news for Innate Pharma as BMS-backed drug stumbles nov 2017. [2024-05-26]. (原始内容存档于2023-12-29)
doi:10.1038/sj.ejcn.1602188. (原始内容存档于2016-03-09). Ben Goldacre (2012), BadPharma, Fourth Estate, p. 14ff. Kongsted, Hans; Konnerup, Merete. Are more observational